Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo M Leoni

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Seminars in Hematology|May 3, 2011
Conclusion and future directionsLorenzo M Leoni
Seminars in Hematology|May 3, 2011
The evolving role of bendamustine in lymphoid malignancy: understanding the drug and its mechanism of action--introductionLorenzo M Leoni
Seminars in Hematology|May 3, 2011
Bendamustine: rescue of an effective antineoplastic agent from the mid-twentieth centuryLorenzo M Leoni
Seminars in Hematology|May 3, 2011
Mechanism of action: the unique pattern of bendamustine-induced cytotoxicityLorenzo M Leoni, John A Hartley
Best Practice & Research. Clinical Haematology|April 3, 2003
Hairy-cell leukaemia as a model for drug developmentDennis A Carson, Lorenzo M Leoni
Idrugs : the Investigational Drugs Journal|January 15, 2005
The American Society of Hematology--46th Annual Meeting and ExpositionLorenzo M Leoni, Heather Bendall, Christina Niemeyer
Acta Haematologica|December 4, 2003
Apoptosis induced by molecular targeting therapy in hematological malignanciesSouichi Adachi, Lorenzo M Leoni, Dennis A Carson, et al.
Gastroenterology|May 2, 2002
Immunostimulatory DNA ameliorates experimental and spontaneous murine colitisDaniel Rachmilewitz, Fanny Karmeli, Kenji Takabayashi, et al.
Molecular Cancer Therapeutics|December 24, 2005
Homozygous deletions of methylthioadenosine phosphorylase in human biliary tract cancersCollins A Karikari, Michael Mullendore, James R Eshleman, et al.
Blood|February 19, 2005
Cell death of bioenergetically compromised and transcriptionally challenged CLL lymphocytes by chlorinated ATPKumudha Balakrishnan, Christine M Stellrecht, Davide Genini, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Seminars in Hematology|May 3, 2011
Conclusion and future directionsLorenzo M Leoni
Seminars in Hematology|May 3, 2011
The evolving role of bendamustine in lymphoid malignancy: understanding the drug and its mechanism of action--introductionLorenzo M Leoni
Seminars in Hematology|May 3, 2011
Bendamustine: rescue of an effective antineoplastic agent from the mid-twentieth centuryLorenzo M Leoni
Seminars in Hematology|May 3, 2011
Mechanism of action: the unique pattern of bendamustine-induced cytotoxicityLorenzo M Leoni, John A Hartley
Best Practice & Research. Clinical Haematology|April 3, 2003
Hairy-cell leukaemia as a model for drug developmentDennis A Carson, Lorenzo M Leoni
Idrugs : the Investigational Drugs Journal|January 15, 2005
The American Society of Hematology--46th Annual Meeting and ExpositionLorenzo M Leoni, Heather Bendall, Christina Niemeyer
Acta Haematologica|December 4, 2003
Apoptosis induced by molecular targeting therapy in hematological malignanciesSouichi Adachi, Lorenzo M Leoni, Dennis A Carson, et al.
Gastroenterology|May 2, 2002
Immunostimulatory DNA ameliorates experimental and spontaneous murine colitisDaniel Rachmilewitz, Fanny Karmeli, Kenji Takabayashi, et al.
Molecular Cancer Therapeutics|December 24, 2005
Homozygous deletions of methylthioadenosine phosphorylase in human biliary tract cancersCollins A Karikari, Michael Mullendore, James R Eshleman, et al.
Blood|February 19, 2005
Cell death of bioenergetically compromised and transcriptionally challenged CLL lymphocytes by chlorinated ATPKumudha Balakrishnan, Christine M Stellrecht, Davide Genini, et al.
Pageof 2